Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

Sensitive CRISPR-Cas12a-Assisted Immunoassay for Small Molecule Detection in Homogeneous Solution

CRISPR/Cas12a-Powered Competitive Immunosorbent Assay for Small Molecules

Sensitive detection of small molecules by competitive immunomagnetic-proximity ligation assay.

Universal CRISPR/Cas12a-associated aptasensor suitable for rapid detection of small proteins with a plate reader

Aptamer-Linked CRISPR/Cas12a-Based Immunoassay

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Aptamer Assisted CRISPR-Cas12a Strategy for Small Molecule Diagnostics.

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

Immunoassay of Small Molecule Mediated by a Triply Functional DNA

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

Sensitive Small Molecule Aptasensing based on Hybridization Chain Reaction and CRISPR/Cas12a Using a Portable 3D-Printed Visualizer

Development of a CRISPR/Cas12a-facilitated fluorescent aptasensor for sensitive detection of small molecules

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules

Accelerated CRISPR/Cas12a-based small molecule detection using bivalent aptamer.

Accelerated Crispr/Cas12a-Based Small Molecule Detection Using Bivalent Aptamer

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

A novel universal small-molecule detection platform based on antibody-controlled Cas12a switching

Fusing Allosteric Ribozymes with CRISPR‐Cas12a for Efficient Diagnostics of Small Molecule Targets

Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications

CRISPR/Cas12a Assay for Amol Level microRNA by Combining Enzyme-free Amplification and Single Particle Analysis